Conferences and Meetings on Oncology

BioLEAGUES

Worldwide BioLEAGUES organize global cancer conferences to bring new innovations by updating the latest research on various topics. On completing our first series on Oncology, now we are organizing our next series “2nd Indo-Oncology Summit-19”. The dates of the Oncology Conference are Nov 14-16, 2019at Eastern India, Bhubaneswar. Cancer in India is the most threatening disease for the past years. This Cancer meeting will connect India with global Oncologists. We assure you to provide a magnificent global platform for all the Students, Researchers, Professors, Doctors, Business delegates. This Cancer Conference gathering would benefit the global Cancer Committee with the recent updates in Cancer Treatment and ways to proceed further. Our Indo-Oncology Summit includes Keynote speech, Plenary Speech, Work Shop, Seminars, Video Presentation to cover all aspects. Over topics enable all Oncologists and researchers to present and publish their research work at our Oncology Conference. This Covers Anal Cancer, Blood Cancer, Brain Cancer, Lung Cancer, Liver Cancer, Bone Cancer, GI Cancer, Head and Neck Cancer, Gynecology, Radiation Oncology, etc., This Cancer Congress will put forth highly interactive environment and provides an international certificate from our International Organizing Committee Members. This Cancer Conference allows interacting face to face with the global Oncology Committee Members, Researchers, Doctors, Oncologists, OCMs and others. This meeting helps all the young researchers and clinicians for better understanding and for improving their knowledge in that particular field. Also, we provide an opportunity for all the participants to publish their papers in indexed journals after presenting at the Oncology Conference.

Phone: [8870914854];     Email: indooncologysummit@gmail.com

Anal Cancer Brain Tumor Bone Cancer Blood Cancer Skin Cancer Breast Cancer Head and Neck Cancer Colorectal Cancer Cervical Cancer Eye Cancer Esophageal Cancer Gastrointestinal Cancer Gall Bladder Cancer Kidney Cancer / Renal Cancer Liver Cancer Lung Cancer Leukemia Lymphoma Meyloma Ovarian Cancer Prostate Cancer Stomach Cancer Gastric Cancer Uterine Cancer Vaginal Cancer Cancer Diagnosis Cancer Screening Cancer Surgery Cancer Treatment Latest Research in Cancer Radiation Oncology Gynecologic Oncology Cancer Epidemiology Immuno-oncology Cancer Vaccines Cancer Stem Cells Cancer Clinical Trials and Drugs Biomarkers Business Entrepreneur Meet

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than 1,100 delegates from 36 countries, including 70% from pharma and biotech organizations, convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. The 2019 event will feature 1,300 attendees, 260 speakers, 25 problem-solving breakout discussions, 250 scientific posters, 100+ industry-leading sponsors and exhibitors, and countless networking opportunities.

Email: asaenger@healthtech.com

Engineering, Oncology, Immunotherapy, Expression, Analytical, antibody engineering, protein engineering, bispecifics, biotherapeutics

Biotechnology,    Genomics and Bioinformatics

The Sixth Royal Marsden lung cancer symposium will tackle burning issues and key challenges facing clinicians treating patients with lung cancer. We have assembled a combination of highly knowledgeable faculty members who will be talking on topics including, lung cancer screening, biomarker testing, systemic and local therapies in both NSCLC and SCLC.

Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

This study day will explore aspects of contemporary haemato-oncology practice delivered by a variety of clinicians working within the specialty.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

The programme will be educational and empowering, covering a wide variety of topics presented by some of the leading experts in their field. The day will consolidate and build on your existing knowledge when caring for this complex group of women.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Der Hämato/Onko Refresher findet vom 29. - 30. November 2019 in Köln statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Phone: [+49 (0) 6192 957 89 41];     Email: info@fomf.de

Hämatologie, Onkologie

Hematology,    Continuing Medical Education (CME)

International Congress of Cancer & Clinical Oncology (CCCO-2019) will be held from December 5-7, 2019 in Grand Copthorne Waterfront Hotel Singapore.

CCCO-2019 mainly focuses on current hot topics of cancer research and clinical oncology to accelerate the translation of cutting edge discovery from basic science to clinical level, and further promote international scientific cooperation, debate and exchange. It aims to presents a unique platform for prominent surgeons, doctors, academician, scientists and R&D leaders from pharmaceuticals to obtain and exchange information on advances in the basic research, early diagnosis and treatment of cancer, while considering both global and regional aspects.

Phone: [00852-37194236];     Email: Cecilia@istci.org

Cancer Molecular Biology & Genetics, Cancer Immunology & Immunotherapy, Cancer Prevention and Epidemiology, Cancer Pharmacology, Cancer Screening & Diagnosis, Cancer Metastasis, Cancer Precision Medicine, Cancer Biomarkers, Gastrointestinal Cancer, Gynecologic Cancer, Head & Neck Cancers, Lung Cancer, Blood and Lymphatic Cancers, Radiation and Medical Oncology, Robotic and AI in Surgical Oncology, Liver, Cholecyst and Pancreatic Cancer

The Miami Brain Symposium will focus on state-of-the-art approaches in the management of primary and metastatic brain and spine tumors, along with an understanding of current standards of care as well as a look at future directions. For one full day this symposium will engage participants, as the expert faculty navigate through complex cases and novel treatment strategies and lively panel discussions.

Phone: [786-596-2398];     Email: JulieZ@BaptistHealth.net

Neurooncology CME, Neurooncology Conference, Baptist Health CME, Miami Brain Symposium

Neurology,    Neuroradiology

460,000 new cases of pancreatic cancer in 2018. The congress will focus on translational and clinical pancreatic cancer research including sessions on diagnostics, screening and therapy. Additional topics such as genetic testing, immunology and immunotherapy, management of local disease, etabolism and metabolomics, precision medicine, signaling and oncogenes as well as the tumor microenvironment will be presented.

Martel Sylvie;     Phone: [04 95 09 38 00];     Email: sylvie.martel@mcocongres.com

Pancreas Cancer Oncology Immunology Immunotherapy Endocrinology

Unique in Europe, the TOW (Toulouse Onco Week) invites you to its third edition, from February 1st to 5th, 2020! Organized as part of the World Cancer Day, TOW is unique as to bring together the different actors from research, care, industry and charities in order to better fight cancer. In February 2018, this meeting brought together more than 2 000 participants and was the opportunity for a strong mobilization of the medical and scientific community and hopeful announcements.

Insight Outside;     Email: contact@toulouse-onco-week.org

Can we really improve DNA damaging agents efficacy? Targeted therapies and resistance mechanisms Translating oncoimmunology science into survival Metabolic vulnerabilities–driven therapies

Unique en Europe, la TOW (Toulouse Onco Week) vous donne rendez-vous pour sa troisième édition, du 1er au 5 février 2020! Organisée dans le cadre de la journée mondiale contre le Cancer, la TOW a la particularité de fédérer les acteurs scientifiques, médico-soignants, industriels et associatifs pour mieux combattre le cancer. En février 2018, cette rencontre a réuni plus de 2000 participants et a été l’occasion d’une forte mobilisation de la communauté médico-scientifique et d’annonces porteuses d’espoir.

Phone: [0585954554];     Email: soizic@toulouse-onco-week.org

Can we really improve DNA damaging agents efficacy? Targeted therapies and resistance mechanisms Translating oncoimmunology science into survival Metabolic vulnerabilities–driven therapies

ESMO’s Sarcoma & GIST Symposium is a highly specialised meeting bringing together the most brilliant medical minds working on these tumour types. The Symposium is known as the place of choice for international networking and collaboration, featuring discussions with the key opinion leaders in these rare sub-entities.The Symposium brings translational researchers and clinicians together and builds on an integrated approach for improved patient outcomes.

Phone: [+41 91 97 31 939];     Email: registration@esmo.org

sarcoma, gist, gastrointestinal stromal tumours, rare cancers, translational research, oncology, cancer, soft tissue sarcomas, medical oncology, surgical oncology, radiotherapy, pathology

Evading programmed cell death is a major hallmark of cancer cells and contributes to tumor progression and therapy resistance. Emerging hallmarks such as metabolic plasticity, genomic instability and an immunosuppressive tumor environment allow the tumors to escape from standard cytotoxic as well as targeted therapies. Thus, understanding the underlying mechanisms in appropriate pre-clinical/clinical models is crucial for the design of more effective combination therapies to avoid treatment failure or tumor recurrence. The EACR Special Conference “A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities” is the 5th Conference on this topic. Its objective is to cover recent and exciting developments in the field of cancer research that are crucial to our understanding of the multifaceted role of cell death in tumor initiation, progression and therapy response.

The 4th DNA Repair/Replication Structures & Cancer conference in February 2020 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. This fundamental information will be pivotal for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently 1/20 low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations.

Conference Manager;     Phone: [+441638724137];     Email: admin@fusion-conferences.com

DNA, DNA Repair, DNA replication, RNA, Cancer, DNA damage signaling, cross-talk, Epigenetics, PARP, PARG, metabolic signalling, Mitochondrial replication, apoptosis

Molecular Biology,    Biology

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Phone: [+49 3643 2468-0];     Email: info@kukm.de

Hilaris Conference invite you to be a part of the Oncology conference in Paris, France on February 20-21, 2020 to discuss on the new innovations within the field of Oncology for providing a much better moreover as a healthier life for the individuals from exceptionally prominent people and display of Standard universities.Hilaris Conference on Oncology 2020 pleased to be able to invite those of you ready to share their knowledge towards Oncology as well as those who are knowledge gaining aspirants in a single stage.

Phone: [359-825-18874];     Email: oncologymeet@gmail.com

Oncology conferences, Cancer Conferences 2020, Oncology 2020, Oncology Meeting, symptoms of Cancer, Radiology, Cancer meeting, Breast cancer treatment, About pcos, Cancer conferences in Paris, France, Cancer research, Hilaris Conference

Fusion Conferences Ltd

This meeting aims to present the most recent advances in the mechanistic understanding of DNA metabolic processes at the single-molecule level, using both in vivo and in vitro approaches.

Conference Manager;     Phone: [00441638724137];     Email: admin@fusion-conferences.com

DNA replication, DNA recombination, DNA repair, Transcription, Chromosome dynamics, Genomics

Molecular Biology,    Biology

Secretariat;     Phone: [+82-2-566-6031];     Email: ik2020@iasgo-ksgc2020.org

Esophagus, Stomach, Colon, Pancreas, Liver and Bile Duct, Small Intestine, Basic Translation, Others

Gastroenterology,    Surgery

Fusion Conferences Ltd

This unique meeting will bring together many of the leading figures in nuclear receptor research from across the globe, to discuss emerging roles and their implications for health and disease – and both human and drug development – in an intimate meeting that will generate meaningful idea exchange and interaction that will help to further shape this influential field.

Conference Manager;     Phone: [00441638724137];     Email: admin@fusion-conferences.com

Nuclear receptors and cancer, Nuclear receptors in reproduction, development and metabolism, Nuclear receptors in central systems, Translating nuclear receptors to the clinic, Nuclear receptors in non-malignant disorders, New advances in nuclear receptors research

Molecular Biology,    Biology

Fusion Conferences Ltd

This meeting on "Epigenetics: from mechanisms to disease" will bring together scientists studying chromatin architecture, epigenetics, stem cell biology and cancer. The talks will cover a broad range of topics, including chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation/differentiation, RNA-based mechanisms, transcription regulation, DNA methylation and hydroxymethylation.

Conference Manager;     Phone: [00441638724137];     Email: admin@fusion-conferences.com

chromatin architecture, epigenetics, stem cell biology, cancer, chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation, stem cell differentiation, RNA-based mechanisms, transcription regulation, DNA methylation, hydroxymethylation

Molecular Biology,    Genomics and Bioinformatics

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO)

This EACR-AACR-ASPIC conference on Tumor Microenvironment(TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems.

Email: hello@eaa2020.org

Tumour Microenvironment, Immune-oncology, Computational biology

The 3rd International Cancer Congress (ICC 20) is an educational meeting intended to improve the care of cancer patients in South Asia by educating cancer care providers about the latest developments in the field of cancer, and their applications in local context. This international hematology and oncology conference will feature renowned faculty from the United States, Nepal, and other parts of the world.

The aim of the study day is to facilitate and equip attendees with the knowledge and skills to care for those with communication and swallowing disorders as a result of their oncological diagnosis or treatment.

Conference Team;     Phone: [02078082921];     Email: conferenceteam@rmh.nhs.uk

Duke University Health System Department of Clinical Education and Professional Development

Join an outstanding roster of national urologists, oncologists, and radiologists participating in a comprehensive scientific program that encompasses leading edge updates on the most effective and efficient diagnoses and treatments in the sub-specialties of urology.

Knowing how cells respond to DNA damage is critical to our understanding of tumourigenesis, genomic instability, and the cellular response to DNA-damaging chemotherapy and radiotherapy. DNA damage responses take place in the context of chromatin and in the midst of ongoing transcription and replication. Moreover, the metabolic environment, which is altered in tumour cells, influences these activities. In this conference, we aim to bring together researchers working on understanding DNA damage responses in the context of complex and dynamic cellular environments. This is an exciting and fast moving area, and this conference features an excellent international line-up of speakers. The programme will address the challenges of understanding this complex field and will emphases new experimental approaches for interrogating these pathways. We will also consider how recent advances can be exploited in the clinic.

DNA damage responses, cancer, oncology, Epigenetic, radiotherapy, transcription, immune, repair, tumourigenesis, cellular, genomic

Binaytara Foundation

The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer care. The summit will feature lectures, discussions and presidential-style debates among leaders across the spectrum of healthcare delivery. It is our hope that this summit will lead us in a direction to help thousands of cancer patients and their families who are still deprived of cutting-edge cancer treatment.

Phone: [4255575953];     Email: support@binayfoundation.org

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Conference Manager;     Phone: [00441638724137];     Email: admin@fusion-conferences.com

Epigenetics, Cancer, Chromatin regulatory pathways, RNA modification pathways, DNA modification pathways, Drug discovery

Genomics and Bioinformatics,    Pharmacology and Drug Development

The University of Texas MD Anderson Cancer Center & Peter MacCallum Cancer Centre

MD Anderson Cancer Center - Global Academic Programs (GAP) 2020 Conference is a forum where MD Anderson Cancer Center and its global network of hospitals, health systems and research institutions collaborate to develop impactful, innovative ideas and research that help MD Anderson achieve its mission to end cancer globally. This three-day scientific conference centres our attention on the theme – New Frontiers – Leading Inspired Cancer Care. We are looking forward to highlighting global collaborations that bring to light clinical and translational research, population health and government engagement initiatives.

Phone: [03 6234 7844];     Email: jodi@laevents.com.au

Immunology | The Leading Frontier, Tele Trials, Shared Care, Beyond the Walls | Maintaining a Work / Life Balance, Surviving Translation | Keeping up and Connecting, Facing the Future | Robotics, AI, Deep Machine Learning, Prehabilitation

Over the last few years, the myeloma field has made significant progresses. We have seen fascinating novel drugs being introduced (including innovative cellular therapies), and the whole treatment paradigm is progressively changing.

Like the previous ones, this international meeting aims to deliver state of the art science and research, focused on the latest advances in the field and on improving patient care.

The scientific content will be on the cutting-edge one because the pace of change in multiple myeloma is accelerating.

In addition to the science, you will be able to enjoy this most spectacular city of Paris. We are looking forward to seeing you in Paris next year

Phone: [+972528887612];     Email: moran@cme-congresses.com

Multiple Myeloma, cancer, CAR T Cell

Hematology,    Continuing Medical Education (CME)

Molecular pathology is revolutionising clinical practice in oncology and pathology paving the way for precision medicine, and has evolved into a growing research field. Knowledgeable molecular pathologists are a significant bottle neck for advancing cancer research and patient care. This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.

Email: laura.strachan@eacr.org

Molecular pathology, cancer research, oncology

Oxford Global Conferences

Immuno-Oncology, Cancer Immunology, Cancer Vaccines, Immunotherapy, Oncology Cell Therapy, Antibody Development, T-Cell Engineering, Immune Biology, Combination Therapy, CAR-T Cell Therapy, Checkpoint Inhibitors, Bispecific, Assay Development, Cancer Genetics/Genomics, Personalised Medicine, Biomarker, Translational Immunology, Preclinical Development, Clinical Oncology, Clinical Trial Management, Clinical Development

German Cancer Reseach Center Heidleberg (DKFZ) and University Hospital Heidelberg

The fast technological development and the rapid clinical implementation of MRI for radiotherapy applications is currently one of the most exciting as well as most challenging developments in radiation oncology. With this science symposium we would not only like to bring together specialists from all involved disciplines, but also to foster a discussion about the scientific direction of the field. The latest developments in physics and technology of MR-guided radiotherapy as well as clinical directions and results will be presented.

Phone: [+49 6221 423481];     Email: mrinrthd@dkfz-heidelberg.de

MR guidance, image guidance, adaptive radiotherapy, MR imaging, functionall imaging and others

Biophysics, Medical Physics,    Radiology: Nuclear Magnetic Resonance Imaging

EACR 2020 is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Email: hello@eacr2020.org

Artificial Intelligence, Cancer Genomics, Immuno Genomics, Cancer Models, Metastasis, Lineages, DNA Damage, Vital Imaging, Metabolism, Microbes

MCI Deutschland GmbH

Organizer;     Phone: [+49 30 204590];     Email: degro@mci-group.com

Ultra-High Dose Rates, Hypofractionation in curative therapy, Oligoma Tastasis, Synergies with Immunotherapy, Artificial Intelligence and Radiomics, MRI-guided Radiation Therapy, DEGRO: The First 25 Years; the next 25 years, Brachytherapy: Status and Development

This conference will focus on three major areas: First, it will present new approaches to generate precise and complex genetic alterations in mice and other animals to better “humanize” models and allow for in vivo studies of cancer gene function. Second, it will highlight studies to investigate fundamental mechanisms of cancer initiation and progression, including the cell of origin of tumors, their evolution, their metabolism, and their interactions with the immune system. Finally, the meeting will explore how genetically engineered animal models can help evaluate the efficacy of novel therapeutic approaches and to decipher mechanisms of therapeutic resistance.

Conference Manager;     Phone: [00441638724137];     Email: admin@fusion-conferences.com

New technologies for cancer modelling, Modeling pre-cancers and tumor initiation, Cancer metabolism, Cancer/immune interactions and tumor microenvironment, Metastasis, Preclinical trials and resistance, Oncology, Animal Modeling

Biology,    Translational Medicine, Clinical Trials

European Association for Cancer Research & European Society of Oncologic Imaging

This new conference is organised by the European Association for Cancer Research (EACR) and the European Society of Oncologic Imaging (ESOI).Our ability to understand and treat cancer is critically dependent upon imaging. This meeting will bring together imaging experts in both clinical and basic research arenas to present their latest research and discuss how to integrate understanding across length scales, imaging modalities, and cancer types. Improved clinical imaging has the power to transform the detection and biologic characterisation of early lesions and the identification of those patients with more advanced disease for tailoring and monitoring personalised therapies. Further, the development of new therapies depends on improved understanding of cancer biology; small animal imaging and imaging tumours with cellular and sub-cellular resolution can elucidate heterogeneity in cancer cell state and interactions with stromal cells, which provide new opportunities for therapeutic intervention. This conference is aimed at clinical and experimental cancer researchers working with, or interested in, the broad range of imaging modalities including US and photoacoustic, CT and micro CT, MRI, PET/CT and PET/MR hybrid imaging, as well as optical techniques. Data analysts dealing with imaging data science using deep learning/machine learning, are also explicitly encouraged to attend.

Email: claire.sullivan@eacr.org

Imaging, Oncology, Machine Learning, Deep Learning, Cancer Biology, Personalised Therapies

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide hands-on experience in the several techniques to detect and analyse circulating tumor cells (CTCs), cell free tumor DNA (ctDNA) and proteins. Participants will have the opportunity to learn all aspects ranging from proper sampling through error free sequencing to data analysis. Lectures will also cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics.

EMBL Events;     Phone: [+49 6221 378 8797];     Email: events@embl.de

Hands-on experience on ultra-sensitive mutation detection using sequencing, Applications of digital PCR to the liquid biopsy workflow, Protein analysis in liquid biopsis, Data analysis and interpretations

Medicine (in general),    Analysis

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Phone: [+4936413116390];     Email: julia.wrenczycki@conventus.de